Source:http://linkedlifedata.com/resource/pubmed/id/20873472
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3 Suppl 2
|
| pubmed:dateCreated |
2010-9-29
|
| pubmed:language |
rus
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1997-7298
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
110
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
39-43
|
| pubmed:meshHeading |
pubmed-meshheading:20873472-Acetamides,
pubmed-meshheading:20873472-Anticonvulsants,
pubmed-meshheading:20873472-Double-Blind Method,
pubmed-meshheading:20873472-Epilepsies, Partial,
pubmed-meshheading:20873472-Humans,
pubmed-meshheading:20873472-Placebos,
pubmed-meshheading:20873472-Randomized Controlled Trials as Topic,
pubmed-meshheading:20873472-Treatment Outcome
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
[Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials].
|
| pubmed:publicationType |
Journal Article
|